PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Exosome formulation developed to deliver antibodies for choroidal neovascularization therapy

Exosome formulation developed to deliver antibodies for choroidal neovascularization therapy
2021-07-26
(Press-News.org) Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences, Beijing Chaoyang Hospital and the University of Queensland have developed a new formulation based on regulatory T-cell exosomes (rEXS) to deliver vascular endothelial growth factor (VEGF) antibodies for choroidal neovascularization therapy. The study was published in Nature Biomedical Engineering on July 26. Ocular neovascularization is often associated with age-related macular degeneration, diabetic retinopathy and other ocular diseases, which can cause severe vision loss. The present treatment for ocular neovascular disease in clinic is intravitreal injection of VEGF antibodies (aV) to block the activity of VEGF and suppress pathogenic angiogenesis. However, this therapy alone faces problems of fast metabolism with the aqueous humor, poor accumulation in lesions and limited efficacy. A considerable proportion of patients still show incomplete response to above aV treatment. In this study, the researchers collected aqueous humor samples from a large cohort of patients and quantified VEGF and other proinflammatory cytokines. "We observed a strong association between inflammation and high VEGF expression in aqueous humor samples," said Prof. TAO Yong from Beijing Chaoyang Hospital. Thus, they proposed a synergistic therapeutic approach that combines anti-VEGF and anti-inflammatory therapies. Following this approach, exosomes isolated from regulatory T-cells were utilized to conjugate aV using a peptide linker (cL), which was subject to cleavage by matrix metalloproteinases (MMPs) in inflammatory lesions. "This design concept could achieve efficient spatiotemporal delivery for combination therapy. After intravitreal injection, rEXS-cL-aV exploited the ability of rEXS to localize in neovascularization lesions and, upon MMP-mediated cleavage, released rEXS and aV to suppress inflammation and VEGF activity, respectively," said Prof. WEI Wei from IPE. The potent therapeutic efficacies were confirmed in both murine and nonhuman primate models of choroidal neovascularization. "This study is still at the preclinical stage. Given that rEXS can be produced from the patients' own cells and aV has been approved for clinical use, our rEXS-cL-aV has the potential for translation to clinic," said Prof. YU Di from the University of Queensland. A peer reviewer from Nature Biomedical Engineering said, "The technology is novel and the treatment efficacy is impressive." The reviewer also emphasized that "collectively, the work provides a substantial technological and potentially therapeutic advance for the treatment of neovascular disease."

INFORMATION:


[Attachments] See images for this press release:
Exosome formulation developed to deliver antibodies for choroidal neovascularization therapy

ELSE PRESS RELEASES FROM THIS DATE:

Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose

2021-07-26
BOSTON - In a multi-hospital analysis of individuals who experienced an allergic reaction to their first mRNA COVID-19 vaccine dose, all patients who went on to receive a second dose tolerated it without complications. The research, which was led by allergists at Massachusetts General Hospital (MGH) and is published in JAMA Internal Medicine, indicates that a first dose reaction to COVID-19 vaccination should not keep people from getting a second dose. Allergic reactions after mRNA COVID-19 vaccinations have been reported to be as high as 2%, with anaphylaxis--a life-threatening whole-body allergic reaction--occurring in up to 2.5 per 10,000 people. ...

Plant root-associated bacteria preferentially colonize their native host-plant roots

Plant root-associated bacteria preferentially colonize their native host-plant roots
2021-07-26
Plants, including crops such as rice and wheat, obtain their essential mineral nutrients and water through their roots, making them an important interface between plants and the soil environment. The roots of land plants associate with a wide range of microbes - including bacteria - that are recruited from the surrounding soil and assemble into structured communities known as the root microbiota. These microbial communities are sustained by the plant host, which provides them with nutrients, primarily in the form of organic carbon compounds secreted by the root. In turn, these commensal bacteria mediate multiple processes ...

Rare inherited variants in previously unsuspected genes may confer significant risk for autism

2021-07-26
New York, NY (July 26, 2021) - Researchers have identified a rare class of genetic differences transmitted from parents without autism to their affected children with autism and determined that they are most prominent in "multiplex" families with more than one family member on the spectrum. These findings are reported in Recent ultra-rare inherited variants implicate new autism candidate risk genes, END ...

International experts call for a unified public health response to NAFLD and NASH epidemic

2021-07-26
Bethesda, MD (July 26, 2021) -- There is an urgent need to develop and implement effective screening, diagnosis and treatment strategies for patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), common liver conditions with a rising burden in the U.S. and globally. This is particularly important for the most at-risk patients, those with diabetes and obesity. As a critical first step, the American Gastroenterological Association (AGA) -- in collaboration with seven professional associations -- convened an international conference of 32 experts to develop a multidisciplinary action plan to improve care for the growing population of patients with NAFLD ...

International collaboration of scientists rewrite the rulebook of flowering plant genetics

International collaboration of scientists rewrite the rulebook of flowering plant genetics
2021-07-26
How do you study a group of organisms with over 300,000 species, dispersed across all seven continents, and with up to 50 times as much DNA content as the human genome? This is the question posed to biologists studying the evolutionary history of flowering plants, called angiosperms, whose rapid diversification was so convoluted a problem that Darwin referred to it as the 'abominable mystery.' This month, both the American Journal of Botany (AJB) and Applications in Plant Sciences (APPS) are devoting their July issues to what has recently become a turning point in the way scientists study the relationships among flowering plants. Dubbed Angiosperms353, the initiative combines ...

Improving air quality reduces dementia risk, multiple studies suggest

Improving air quality reduces dementia risk, multiple studies suggest
2021-07-26
DENVER, JULY 26, 2021 -- Improving air quality may improve cognitive function and reduce dementia risk, according to several studies reported today at the END ...

Misplaced trust: When trust in science fosters pseudoscience

2021-07-26
The Covid-19 pandemic and the politicization of health-prevention measures such as vaccination and mask-wearing have highlighted the need for people to accept and trust science. But trusting science isn't enough. A new study finds that people who trust science are more likely to believe and disseminate false claims containing scientific references than people who do not trust science. Reminding people of the value of critical evaluation reduces belief in false claims, but reminding them of the value of trusting science does not. "We conclude that ...

Two types of blood pressure meds prevent heart events equally, but side effects differ

2021-07-26
DALLAS, July 26, 2021 -- People who are just beginning treatment for high blood pressure can benefit equally from two different classes of medicine - angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) - yet ARBs may be less likely to cause medication side effects, according to an analysis of real-world data published today in Hypertension, an American Heart Association journal. While the class of blood pressure-lowering medicines called angiotensin-converting enzyme (ACE) inhibitors may be prescribed more commonly, angiotensin receptor blockers (ARBs) work just as well and may cause fewer side effects. Currently, ACE inhibitors are prescribed more commonly than ARBs as a first-time blood pressure ...

New statement provides path to include ethnicity, ancestry, race in genomic research

2021-07-26
DALLAS, July 26, 2021 -- Genomic studies have produced advances in how to calculate and reduce heart-disease risk, however, the benefits don't necessarily apply to people from historically marginalized racial and ethnic groups and Indigenous populations. Efforts must be made to eliminate barriers to increase their participation in genomic research, according to a new scientific statement from the American Heart Association, published today in the Association's journal Circulation: Genomic and Precision Medicine. "Profound breakthroughs in genetic and genomic science are rapidly improving our ability to prevent, detect and treat cardiovascular ...

Among effective antihypertensive drugs, less popular choice is slightly safer

2021-07-26
NEW YORK, NY (July 26, 2021)--Two types of drugs that are recommended as a first treatment for patients with high blood pressure were found equally effective in improving cardiovascular outcomes, but the more popular type causes slightly more side effects, finds a multinational observational study led by researchers at Columbia University Vagelos College of Physicians and Surgeons. The study, which analyzed claims and electronic health data from millions of patients worldwide, is the largest to compare the safety and efficacy of angiotensin-converting ...

LAST 30 PRESS RELEASES:

Study tracks chromium chemistry in irradiated molten salts

Scientists: the beautiful game is a silver bullet for global health

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

[Press-News.org] Exosome formulation developed to deliver antibodies for choroidal neovascularization therapy